Eledon
ELDN
Eledon (ELDN) news
Recent news
Eledon Pharmaceuticals Q2 net income USD -31.63 million
AInvest Wire · Aug 13, 2026Eledon Pharmaceuticals Q2 operating expenses USD 22.869 million
AInvest Wire · Aug 13, 2026Newcelx: FDA feedback supports planned development strategy
NewCelX Ltd. (Nasdaq: NCEL) has taken a significant step in its clinical development strategy for NCEL-101, an advanced cell therapy candidate for Type 1 Diabetes, by engaging in a Pre-IND meeting with the U.S. Food and Drug Administration (FDA). The company is working in collaboration with Eledon…
AInvest Wire · Jul 1, 2026Natera, Eledon Pharmaceuticals reach strategic pact
AInvest Wire · Jun 25, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.